Vertex Pharmaceuticals said on Saturday its gene therapy helped children aged between 5 and 11 years with sickle cell disease ...
4h
CT joins national push to open access to million-dollar sickle cell gene therapies through Medicaid
About 100,000 people in the U.S. have sickle cell disease, a condition that primarily affects people of color, the CDC says.
Encoded Therapeutics has linked its Dravet syndrome gene therapy ETX101 to a 78% reduction in seizures, keeping the biotech ...
The European Union has reached a preliminary deal on how to regulate gene-edited crops in a move that could ease the development of new varieties in a region long wary of biotech innovations in food.
Regeneron is adding its name to Tessera Therapeutics’ unique in vivo gene writing program, inking a deal that lets it in on a ...
Kian Sadeghi, the 25-year-old founder and CEO at Nucleus Genomics, tells "CBS Mornings" that parents have every right to select the qualities and traits they desire in their child.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback